Danone Sa · EURONEXT:BN

Danone Sa — FY2014 Earnings Presentation

74 slides from Danone Sa's earnings presentation, Feb 20, 2015

  1. Slide 1: FY 2014 Results

    FY 2014 Results February 20, 2015 1

  2. Slide 2: Disclaimer

    DISCLAIMER This document contains certain forward-looking statements concerning Danone. Although Danone believes its expectations are based on reasonable assumptions, these forward- looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materia

  3. Slide 3: A Year of Turbulences

    A YEAR OF TURBULENCES Index : base 100 Jan 2009 UKRAINIAN TENSIONS 140 Milk price Europe 120 100 80 Danone average price/kg Europe MILK PRICES 60 2008 2009 2010 2011 2012 2013 2014 Source : European Milk Market Observatory OIL PRICE DECLINE ARGENTINA’S PESO DECLINE EBOLA $ oil price 120 100 80 60 12

  4. Slide 4: 2014 Key Achievements

    2014 KEY ACHIEVEMENTS MANAGING THE EQUATION IN EUROPE PLANTING SEEDS FOR THE FUTURE Europe sales growth trend evolution 2013 2014 < 2013 2014 ENHANCING OUR PLATFORMS CONSOLIDATING ASIA USA & Russia N°1 in MS

  5. Slide 5: Solid Performance in a Volatile Environment

    SOLID PERFORMANCE IN A VOLATILE ENVIRONMENT 2014 targets FY 2014 announced FY 2013 Sales growth(1) At least 4.5% 4.7% 12.59% Trading operating margin(1) Stable ± 20bps -12bps Free cash-flow excluding Around €1.5 bn €1,401 mln exceptional items(2) (1) Like-for-like: excludes the impact of changes in

  6. Slide 6: 2014: A Year of Transformation

    2014: A YEAR OF TRANSFORMATION October New role Operational agenda Strengthened duties Set up and implementation Thoughts and design of a new governance 6

  7. Slide 7: Governance – A New Organization

    GOVERNANCE – A NEW ORGANIZATION ONE 15 Board members 71% independent BOARD ONE CHAIRMAN ONE CEO 7

  8. Slide 8: Governance – A New Board Member

    GOVERNANCE – A NEW BOARD MEMBER Appointment of a new Board member (independent) proposed to next AGM SERPIL TIMURAY 2015 Board composition characteristics (subject to the approval of the Shareholders’ Meeting) • Rate of independence: 77% • Average age of Directors: 55.4 years • Percentage of women:

  9. Slide 9: Agenda

    AGENDA 2014: A solid performance in a volatile environment - Pierre-André Terisse, CFO 2015: Priorities and stakes – Emmanuel Faber, CEO Questions & Answers 9

  10. Slide 10: Agenda

    AGENDA 2014 : A solid performance in a volatile environment - Pierre-André Terisse, CFO 2015 : Priorities and stakes – Emmanuel Faber, CEO Questions & Answers 10

  11. Slide 11: Key Figures

    KEY FIGURES +4.7% like-for-like(1) Sales € 21,144 mln (0.7)% reported +3.7 % like-for-like(1) Trading operating income € 2,662 mln (5.2)% reported -12 bps like-for-like(1) Trading operating margin 12.59% (60) bps reported +3.6% like-for-like(1) (2) Underlying net income € 1,561 mln (4.6)% reported +

  12. Slide 12: 2014: Keys to Read Our Financial Performance

    2014: KEYS TO READ OUR FINANCIAL PERFORMANCE EUROPE: SIGNS OF SUCCESS ALMA: NAVIGATING IN VOLATILE MARKETS Mix management High inflation inflation price increase 2014 Forex inflation Argentine FanMilk Margin stabilized treatment impairment Restructuring ) ( portfolio inflation Investment Asia Africa

  13. Slide 13: FY 2014 - Sales Growth Analysis

    FY 2014 - SALES GROWTH ANALYSIS +4.7% Like-for-like (0.7)% reported (5.5)% 6.2% €21,144 mln 0,1% €21,298 mln (1.5)% 2013 Currency Scope & others Volume Value 2014 13

  14. Slide 14: Q4 2014 - Sales Growth Analysis

    Q4 2014 - SALES GROWTH ANALYSIS +7.5% Like-for-like +5.6% 7.8% Reported (1.4)% (0.5)% (0.3)% €5,261 mln €4,981 mln Q4 2013 Currency Scope & others Volume Value Q4 2014 14

  15. Slide 15: Total Company – A Solid Performance in a Volatile Environment

    TOTAL COMPANY – A SOLID PERFORMANCE IN A VOLATILE ENVIRONMENT Like-for-like sales growth Q4 2014 figures after treatment of over inflation for the full year 7.5% 6.9% 6.5% 5.6% 4.8% 4.7% 4.2% 2.9% 2.2% 2.3% FY 13 FY 14 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Solid performance in all markets

  16. Slide 16: Geographical Dynamics

    GEOGRAPHICAL DYNAMICS Weight based on 2014 sales Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 FY 13 FY 14 4,8% 2,0% 2,8% 0,5% 0,1% EUROPE (2,4)% (0,9)% (0,4)% Weight: (3,0)% 40% (5,1)% 11,1% 10,0% 10,2% 10,2% 8,5% 7,8% 7,0% NORAM 5,0% 3,3% CIS 2,0% Weight: 22% FY 13 FY 14 Q1 13 Q2 13 Q3 13 Q4 13

  17. Slide 17: Sales Performance by Division

    Sales performance by Division 17 17

  18. Slide 18: Fresh Dairy Products – Focusing on Key Battles

    FRESH DAIRY PRODUCTS – FOCUSING ON KEY BATTLES TO FACE EXCEPTIONAL MILK INFLATION Like-for-like sales growth Price/mix Volume 4.6% 4.9% 3.2% 8.1% 7.6% 9.8% 1.5% 7.8% 2.6% 2.9% 4.1% 3.9% 6.8% 0.7% 2.4% 1.5% 0.2% 3.6% 1.7% 1.7% 0.8% 0.7% 0.5% (1.0)% (1,0)% (3.7)% (6.6)% (7.4)% (7.1)% (7.8)% FY 13 FY 1

  19. Slide 19: Fresh Dairy Products – Selected Innovations Q4

    FRESH DAIRY PRODUCTS – Selected innovations Q4 Activia Superfruits Danone Cremoso Dan’up relaunch Russia Spain Brazil Yogurisimo Cremix & Stick Actimel Kids Danimals Squeezables Argentina Russia United States 19

  20. Slide 20: Waters – Sustained Strong Growth

    WATERS – SUSTAINED STRONG GROWTH Like-for-like sales growth 16.9% Price/mix Volume 13.1% 7.5% 12.3% 11.6% 11.8% 11.2% 10.5% 3.3% 8.9% 6.1% 3.5% 4.1% 8.6% 8.1% 4.4% 3.4% 2.1% 3.5% 4.0% 9.4% 9.0% 8.3% 6.8% 7.5% 7.1% 7.0% 6.0% 5.4% 4.6% FY 13 FY 14 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Very s

  21. Slide 21: Waters – Selected Innovations Q4

    WATERS – Selected innovations Q4 X-Mas Evian by Kenzo X-Mas Badoit Salus Uno Worldwide Worldwide Uruguay Mizone Fire We by Ser Villa del Sur Levité sachet China Argentina Argentina 21

  22. Slide 22: Early Life Nutrition – Rebuild Strong Platforms of Growth

    EARLY LIFE NUTRITION – REBUILD STRONG PLATFORMS OF GROWTH 28.1% Like-for-like sales growth 19.2% 16.6% 17.1% 13.5% 9.3% 9.3% 6.1% 10.8% 11.5% 4.4% 9.9% 3.6% 7.8% 4.3% 2.7% 1.7% (0.7)% (4.8)% (7.3)% (5,9)% FY 13 FY 14 (7.9)% (1.0)% (2.9)% (1.3)% (6.9)% (7.7)% (1.3)% (8.6)% (9.2)% Q1 13 Q2 13 Q3 13 Q4

  23. Slide 23: Early Life Nutrition – Selected Innovations Q4

    EARLY LIFE NUTRITION – Selected innovations Q4 Aptamil Pronutra+ Milk Cereals Milupa Profutura Mama Nutrilon AR Switzerland Germany Argentina Aptamil Profutura Nutrilon Profutura Germany Argentina 23

  24. Slide 24: Medical Nutrition – Improving Dynamics

    MEDICAL NUTRITION – IMPROVING DYNAMICS Like-for-like sales growth Price/mix Volume 10.1% 8.7% 7.9% 6.3% 5.8% 7.3% 4.5% 2.4% 5.8% 6.4% 2.3% 0.1% 1.1% 0.3% 5.2% 4.7% 1.6% 0.9% 1.1% 7.4% 6.2% 6.2% 5.6% 6.3% 5.5% 5.6% 4.8% 3.6% 4.3% (1.6)% FY 13 FY 14 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Key

  25. Slide 25: Medical Nutrition – Selected Innovations Q4

    MEDICAL NUTRITION – Selected innovations Q4 < Terug Overzicht eiwitten GRAFIEK MET EIWIT INNAME EN DAGELIJKS DOEL Weekly compliance 83% Doel: 30 gr per dag 15 feb 21 feb NutriApp to monitor calorie and protein intake Netherlands Infatrini Lophlex LQ Juicy Worldwide 13 countries 25

  26. Slide 26: Trading Operating Income and Margin

    TRADING OPERATING INCOME AND MARGIN FY 2013 FY 2014 € mln Trading operating income 2,809 2,662 Other operating items (681) (511) Operating income 2,128 2,151 Trading operating margin 13.19% 12.59% 26

  27. Slide 27: 2014 - Margin Development

    2014 - MARGIN DEVELOPMENT Reported (60) bps (207) bps (20) bps (28) bps (12) bps 13.19% 12.59% Margin FY 2013 Scope Forex Like-for-like Margin FY 2014 27

  28. Slide 28: 2014 - Managing Inflation Through Price & Mix

    2014 - MANAGING INFLATION THROUGH PRICE & MIX LIKE-FOR-LIKE MARGIN BRIDGE (12) bps (226) bps 252 bps (20) bps (81) bps 63 bps FY 2013 Volume Pricing & Mix Input cost & Other COGS A&P FY 2014 inflation 28

  29. Slide 29: Record Milk Prices

    RECORD MILK PRICES DANONE FARMGATE PRICE 2006-2014 €/Ton 400 350 300 250 200 29

  30. Slide 30: Trading Operating Margin by Business Line & Geographical Area

    TRADING OPERATING MARGIN by business line & geographical area Like-for-like FY 2013 FY 2014 € mln change Fresh Dairy Products 10.35% 9.28% (67) bps Waters 13.04% 12.88% +93 bps Early Life Nutrition 19.62% 18.83% (40) bps Medical Nutrition 18.16% 18.28% +89 bps Europe 14.42% 15.67% +158 bps CIS+Noram

  31. Slide 31: From Operating Income to EPS

    FROM OPERATING INCOME TO EPS FY 2013 FY 2014 Non-current FY 2014 € mln underlying underlying items Trading operating income 2,809 2,662 - 2,662 Other operating items - (511) (511) Operating income 2,809 2,662 (511) 2,151 Total financial expenses (311) A UPDATER (309) (3) (312) Income tax (750) (716)

  32. Slide 32: EPS Down on Forex, Up Without Forex and Scope

    EPS DOWN ON FOREX, UP WITHOUT FOREX AND SCOPE Reported (5.6)% (7.8)% +2.5% (0.3)% €2.78 € 2.62 Underlying EPS FY 2013 Currency Scope Like-for-like growth Underlying EPS FY 2014 32

  33. Slide 33: Cash Bridge

    CASH BRIDG ©) DANONE €min Cash from Working capital Capex Sales of assets FCF excl Plan for savings FCF reported operating variation and transaction European plan and adaptation activities Fees in Europe 33

  34. Slide 34: Cash Drivers

    CASH DRIVERS FREE CASH-FLOW EXCLUDING EXCEPTIONAL ITEMS (€ MLN) 2 088 1 713 1 874 1 549 1 401 2010 2011 2012 2013 2014 WORKING CAPITAL (€ MLN) CAPITAL EXPENDITURES (€ MLN) 2010 2011 2012 2013 2014 (989) (1,199) (1,528) 1 039 (1,769) (1,861) 885 976 984 832 2010 2011 2012 2013 2014 % of sales -5.8% -

  35. Slide 35: 2014 - FCF to Net Debt Change

    2014 - FCF TO NET DEBT CHANGE € mln 35

  36. Slide 36: A New Rating for More Flexibility

    A NEW RATING FOR MORE FLEXIBILITY AND A CONFIRMED HIGH-QUALITY SIGNATURE CHANGE OF RATING €1.3BN DUAL-TRANCHE BOND ISSUE Including a tranche of 10-year fixed rate bonds 2014 December 2014 of €750 million, priced at mid swap +48 basis points (coupon of 1.125%). A- A- stable outlook negative outlook A

  37. Slide 37: Synthetic Balance Sheet

    SYNTHETIC BALANCE SHEET Assets(1) Liabilities € mln December 13 December 14 December 13 December 14 Shareholders’ equity 11 745 10 729 Intangible assets 16 234 16 308 7 764 Net debt(2) 7 966 7 921 Other assets 6 682 2 527 2 785 Other liabilities Working capital 5 745 6 075 Working capital 3 977 4 21

  38. Slide 38: 2014 CSR Achievements

    2014 CSR ACHIEVEMENTS: CONTINUING TO BUILD SUSTAINABLE PERFORMANCE Carbon intensity -42 % 2008-2014 On track to meet objective of >50% reduction 2008-2020 BRINGING HEALTH Water intensity THROUGH FOOD TO AS MANY PEOPLE AS -4 % in 2014 On track to meet objective of >60% reduction 2000-2020 POSSIBLE Lo

  39. Slide 39: Agenda

    AGENDA 2014: A solid performance in a volatile environment - Pierre-André Terisse, CFO 2015: Priorities and stakes – Emmanuel Faber, CEO Questions & Answers 39

  40. Slide 40: Key Priorities Since October 2014

    KEY PRIORITIES SINCE OCTOBER 2014 A NEW EXECUTIVE TEAM A NEW BUSINESS ORGANIZATION 4 CATEGORIES A DEEP DIVE INTO BUSINESS 40

  41. Slide 41: Leverage Our Strengths and Opportunities

    LEVERAGE OUR STRENGTHS AND OPPORTUNITIES OUR MISSION OUR TALENTS 81% LONG-TERM COMMITMENT OUR STRONG BRANDS OUR GEOGRAPHICAL FOOTPRINT 41

  42. Slide 42: Danone 2020 as a Guiding Vision

    DANONE 2020 AS A GUIDING VISION 42

  43. Slide 43: 2015: A First Step Towards 2020

    2015: A FIRST STEP TOWARDS 2020 2014 2015 … 43

  44. Slide 44: Europe - Reinforce Our Base Camp

    EUROPE - REINFORCE OUR BASE CAMP EUROPE EUROPE Weight: LFL 40% growth: +2.0% 44

  45. Slide 45: Europe - Fresh Dairy Products

    EUROPE - FRESH DAIRY PRODUCTS EUROPE BREAKDOWN VOLUME/VALUE GROWTH (%) 2014 BRANDS PERFORMANCE Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q4 performance Full-year performance 8% Positive in Germany, 4% Italy & UK 0% +7.6% (4)% (8)% (12)% Price/mix Positive in (16)% France & Iberia € 20 mln Volu

  46. Slide 46: Europe – Medical Nutrition

    EUROPE – MEDICAL NUTRITION EUROPE PERFORMANCE IMPROVEMENT IN A TOUGH CONTEXT STRONG LEADER IN WESTERN EUROPE Reimbursement pressure Competition intensity Nordics #1 EUROPE > +5% sales growth UK/Ireland #1 #1 #2 TRUSTED BRANDS CONTINUOUSLY INNOVATING #1 #1 #1 < Terug Overzicht eiwitten GRAFIEK MET EI

  47. Slide 47: NORAM / CIS - Two Powerhouses in Large Markets

    NORAM / CIS - TWO POWERHOUSES IN LARGE NORAM MARKETS CIS NORAM Weight: CIS LFL 22% growth: +5.0% 47

  48. Slide 48: NORAM / CIS - Fresh Dairy Products USA

    NORAM NORAM / CIS - FRESH DAIRY PRODUCTS USA CIS LEADING THE YOGURT CATEGORY DANNON’S FUTURE GROWTH PILLARS 40% Average value market shares CONSUMERS Danone(1) 30% Competitor 1 20% Competitor 2 10% 2011 2012 2013 2014 (1) Danone : including Stonyfield and YoCrunch Source: IRI Multi Outlet RETAILERS

  49. Slide 49: NORAM / CIS - Fresh Dairy Products CIS

    NORAM NORAM / CIS - FRESH DAIRY PRODUCTS CIS CIS RUBLE DEVALUATION SOLID LOCAL PLATFORM 65 • Local brands volume >80% of total portfolio 55 45 • 100% local milk sourcing 35 • 100% local production 25 janv.-13 juil.-13 janv.-14 juil.-14 janv.-15 2014 BRANDS SALES GROWTH RUSSIAN MILK PRICE INFLATION E

  50. Slide 50: ALMA – A Growth Platform for Today & Tomorrow

    ALMA – A GROWTH PLATFORM FOR TODAY & ALMA TOMORROW Weight: ALMA LFL 38% growth: +7.4% 50

  51. Slide 51: ALMA - LATAM

    ALMA - LATAM ALMA LATAM KEY-DRIVER COUNTRIES SOLID MODEL BEYOND INFLATION PCC yogurt (kg/pers) evolution 8 #1 #1 7 Positions in each market 6 5 2014 Danone Waters Latam #4 #1 4 MS: 35.5% / +0.8 pt vs LY 3 2 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Source: Eurom

  52. Slide 52: ALMA – Opportunities of Growth in Asia

    ALMA – OPPORTUNITIES OF GROWTH IN ASIA ALMA WATERS: BRAND & CATEGORY PERFORMANCE 2014 sales growth Aquadrinks Asia > +30% A STRATEGIC ALLIANCE WITH MENGNIU Mizone > +30% Aqua +19% Danone’s stake in Mengniu: 9.9%  2nd biggest shareholder behind COFCO Danone’s stake in Mengniu/Danone Dairy ELN INDONE

  53. Slide 53: ALMA - Early Life Nutrition China

    ALMA - EARLY LIFE NUTRITION CHINA ALMA A BROAD PORTFOLIO COVERING ALL BABIES’ NEEDS GLOBAL SALES VALUE PER CHANNEL 3 500 (Mln RMB) 3 000 2 500 2 000 1 500 1 000 NUTRILON: INTENSIFY CONNECTIONS WITH CONSUMERS 500 E-commerce MT MBS (Mom & Baby Stores) - E-store Mom & Baby stores 53

  54. Slide 54: ALMA – Africa, a Land of Opportunities

    ALMA – AFRICA, A LAND OF OPPORTUNITIES ALMA (AND CHALLENGES) By 2035,Africa will have a 1 in 4 of the world’s larger working age children is born in Africa population than China 1.2 birth every second 40% of Africans are under 15 in Africa, for a birthrate of 35.4 per 1,000 Twice as many mobiles as

  55. Slide 55: ALMA - Africa, Building the Platform

    ALMA - AFRICA, BUILDING THE PLATFORM ALMA 2008 2014 Presence in over 40 countries x6 €1 bn 2008 2014 55

  56. Slide 56: A Continued Challenging Environment

    A CONTINUED CHALLENGING ENVIRONMENT 56

  57. Slide 57: 2015: Enhance Our Strengths and Keep Building a Sustainable Model

    2015: ENHANCE OUR STRENGTHS AND KEEP BUILDING A SUSTAINABLE MODEL OPTIMIZE INVEST Margin BUILD NURTURE categories 57

  58. Slide 58: 2015 Guidance: Anchor the Model

    2015 GUIDANCE: ANCHOR THE MODEL (1,027) 2015 objectives Sales growth(1) 4% to 5% Trading operating Slightly up margin(1) (1) Like-for-like: excludes the impact of changes in the basis for comparison, which include exchange rates and scope of consolidation 58

  59. Slide 59: Proposal to Increase Dividend at the Next AGM

    PROPOSAL TO INCREASE DIVIDEND AT THE NEXT AGM Dividend proposed at the next AGM on April 29th, 2015 :  € 1.50 per share (+5 ct vs. 2013)  Payment in either cash or shares at shareholders’ option 59

  60. Slide 60: Appendix

    JOOGVVOC » pppenon OOCc Ev) a) JOOOGOVOC

  61. Slide 61: Cash Bridge

    CASH BRIDGE DANONE €min 57 — (784) 59 2,269 Trading Depreciation Taxes Financial Others Cash from Working capital = Capex Sales ofassets FCFexcl Plan forsavings FCF reported Operating results operating variation and transaction European plan and adaptation income activities Fees in Europe 61

  62. Slide 62: Tax Rate Development

    TAX RATE DEVELOPMENT FY 2013 FY 2014 € mln Total income tax (reported) (604) (599) Reported tax rate 32.4% 32.6% Non-current income tax(1) 146 117 Current income tax (750) (716) Underlying tax rate 30.0% 30.5% (1) Tax related to non-current items 62

  63. Slide 63: Share Price & Shareholding

    SHARE PRICE & SHAREHOLDING DANONE SHARE PRICE EVOLUTION DANONE STOCK PERFORMANCE(1) Absolute +4.1% Relative vs. CAC 40 +3.6% Relative vs. Eurostoxx 50 +2.9% SHAREHOLDING BY INVESTOR TYPE (2) INSTITUTIONAL SHAREHOLDING BY GEOGRAPHY (2) France Institutional shareholders United Kingdom 15% 78% 10% Asia

  64. Slide 64: ADR Program

    ADR PROGRAM DRs Outstanding as a % of Total Shares Outstanding 180 5% DRs Outstanding (Millions) % Total Shares Outstanding 160 4% 140 120 3% 100 80 2% 60 40 1% 20 0 0% January February March April May June July August September October November December DRs Outstanding % Total Shares Outstanding Da

  65. Slide 65: Impact of Currencies and Scope - Q4 2014

    IMPACT OF CURRENCIES AND SCOPE - Q4 2014 Fresh Dairy Early Life Medical Waters Total Products Nutrition Nutrition Reported sales growth (5.6)% +14.6% +29.7% +10.3% +5.6% Currency (4.0)% +2.1% +1.1% +1.5% (1.4)% Scope of consolidation (0.6)% +0.2% +0.5% +0.1% (0.5)% Like-for-like sales growth (1.0)%

  66. Slide 66: Impact of Currencies and Scope - FY 2014

    IMPACT OF CURRENCIES AND SCOPE - FY 2014 Fresh Dairy Early Life Medical Waters Total Products Nutrition Nutrition Reported sales growth (5.6)% +7.2% +3.1% +6.7% (0.7)% Currency (6.9)% (5.2)% (3.6)% (1.4)% (5.5)% Scope of consolidation (0.2)% +0.8% +0.6% +0.2% +0.1% Like-for-like sales growth +1.5% +

  67. Slide 67: Q4 2014 Sales by Business & Geographical Area

    Q4 2014 SALES BY BUSINESS & GEOGRAPHICAL AREA Like-for-like Q4 2013 Q4 2014 € mln sales growth Fresh Dairy Products 2,854 2,693 (1.0)% Waters 823 944 +12.3% Early Life Nutrition 956 1,241 +28.1% Medical Nutrition 348 384 +8.7% Europe 1,969 2,105 +4.8% CIS+Noram 1,170 1,042 +2.0% ALMA 1,842 2,114 +14

  68. Slide 68: FY 2014 Sales by Business & Geographical Area

    FY 2014 SALES BY BUSINESS & GEOGRAPHICAL AREA Like-for-like FY 2013 FY 2014 € mln sales growth Fresh Dairy Products 11,790 11,129 +1.5% Waters 3,903 4,186 +11.6% Early Life Nutrition 4,263 4,397 +6.1% Medical Nutrition 1,342 1,432 +7.9% Europe 8,197 8,522 +2.0% CIS+Noram 4,713 4,525 +5.0% ALMA 8,388

  69. Slide 69: Q4 2014 Like-for-Like Sales Growth Breakdown Volume/Value

    Q4 2014 LIKE-FOR-LIKE SALES GROWTH BREAKDOWN VOLUME/VALUE Volume Price/mix Total Like-for-like Fresh Dairy Products (7.8)% +6.8% (1.0)% Waters +9.0% +3.3% +12.3% Early Life Nutrition +11.5% +16.6% +28.1% Medical Nutrition +6.3% +2.4% +8.7% Europe +0.0% +4.8% +4.8% CIS+Noram (8.0)% +10.0% +2.0% ALMA

  70. Slide 70: FY 2014 Like-for-Like Sales Growth Breakdown Volume/Value

    FY 2014 LIKE-FOR-LIKE SALES GROWTH BREAKDOWN VOLUME/VALUE Volume Price/mix Total Like-for-like Fresh Dairy Products (6.6)% +8.1% +1.5% Waters +7.5% +4.1% +11.6% Early Life Nutrition +1.7% +4.4% +6.1% Medical Nutrition +5.6% +2.3% +7.9% Europe (0.9)% +2.9% +2.0% CIS+Noram (6.9)% +11.9% +5.0% ALMA +0.

  71. Slide 71: Cash Flow Statement

    CASH FLOW STATEMENT 2013 2014 € mln Operating income 2,809 2,662 Financial income (311) (309) Income tax (750) (716) Non-current income (487) (397) Depreciation and amortization 711 956 Net change in provisions 78 (51) Dividend received from equity accounted affiliates 27 18 Other cash items (35) (9

  72. Slide 72: Cash Flow Statement

    CASH FLOW STATEMENT 2013 2014 € mln Cash flow provided by operating activities, excluding 2,133 2,154 changes in net working capital Change in working capital 224 35 Cash flow from operations 2,357 2,189 Capital expenditure (1,039) (984) Proceeds from the sale of industrial assets 79 67 Business acq

  73. Slide 73: Cash Flow Statement

    CASH FLOW STATEMENT 2013 2014 € mln Increase in capital and additional paid-in capital 37 33 Purchases of treasury stock (net of disposal) (793) 13 Dividends paid to Danone shareholders (848) (307) Transactions with non controlling interests* (213) (471) Settlement of debt hedge financial instrument

  74. Slide 74: Changes in Exchange Rates

    CHANGES IN EXCHANGE RATES 28.7% OF SALES DENOMINATED IN € % total FY 14 FY 14 vs FY 13 Q4 14 vs Q4 13 sales (avg) (avg) US dollar 10.1% (0.1)% 8.9% Russian ruble 9.4% (17.1)% (26.2)% Chinese yuan 6.5% (0.3)% 7.9% Indonesian rupiah 5.4% (12.0)% 2.7% British pound 5.4% 5.3% 6.5% Mexican peso 5.1% (4.0

Danone — FY2014 Earnings Presentation on 6ix